ChartRow logo
NVO
Novo Nordisk A/SStock · Health Care
$45.97+$1.44 (+3.23%)as of market close, Aug 6, 2026
CompareLLYUNHJNJABBVISRGTMO

NVONovo Nordisk A/S stock price, chart and key statistics

Key stats

Price data

Price
$45.97
Change YTD
-9.65%
Market cap
204.5B
Enterprise value
219.4B
Shares outstanding
4.4B
52W low
$35.12
52W high
$64.16
From 52W high
-28.35%
From 52W low
+30.89%
52W range
37%
Beta
0.74

Volume

Rel volume
0.99×
30D volume
12M
30D $ vol
575.6M

Fundamentals

Sales (ttm)
46.6B
Sales/share
$10.49
EPS (ttm)
$3.48
FCF (ttm)
18B
FCF/share
$4.04
Book value/share
$6.87
Net margin
33.14%
ROE
50.62%
ROA
18.09%
Debt / equity
0.57×
Current ratio
0.80

Growth (CAGR, ttm) · 10Y

Sales
n/a
Net income
n/a
Shares
n/a

Per-share growth (CAGR, ttm) · 10Y

EPS
n/a
Sales/share
n/a
Book value/share
n/a
Dividend/share
n/a
Price
+6.31%
Total return
+8.59%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
13.2×
Fwd P/E
13.4×
P/S (ttm)
4.4×
P/B (mrq)
6.7×
P/FCF (ttm)
11.4×
EV/EBITDA (fy)
10.2×
EV/Sales (ttm)
4.7×
FCF yield (ttm)
8.79%
Dividend yield (fwd)
3.84%
Dividend/share (fwd)
$1.77
Buyback yield (realized, 1y)
0.34%
Shareholder yield (realized, 1y)
4.16%
Buyback yield (cash, ttm)
0.10%
Shareholder yield (cash, ttm)
3.92%

Performance · price return

1D
+3.23%
1W
-10.93%
1M
-5.97%
3M
+0.46%
YTD
-9.65%
1Y
-2.65%
5Y
+0.62%

Financial statements

Open full NVO financials →

Related Health Care

1M
TickerThemePrice1M30D $Vol
NVS
Novartis AG
$154-0.62%295.9M
AZN
AstraZeneca PLC
$161-14.90%597.2M
GSK
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
$52.17-0.67%223.6M
ARGX
argenx SE American Depositary Shares
$875-4.37%273.2M
SNY
Sanofi ADS
$42.89+0.26%152.5M
RVMD
Revolution Medicines Inc.
$198+4.24%463.3M
TEVA
Teva Pharmaceutical Industries Limited American Depositary Shares
$34.81+4.72%179.6M
NTRA
Natera Inc.
$265-3.28%360.8M

Novo Nordisk A/S (NVO) trades at $45.97 with a live price and an interactive chart covering 45+ years of daily price history, plus key valuation metrics. ChartRow also publishes NVO's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full NVO financial statements →